CompletedNot applicableNCT00713037

Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas

Studying Chordoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Massachusetts General Hospital
Principal Investigator
Thomas F. DeLaney, MD
Massachusetts General Hospital
Intervention
Fluoromisonidazole-PET/CT(procedure)
Enrollment
20 enrolled
Eligibility
18 years · All sexes
Timeline
2008 – 2016

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00713037 on ClinicalTrials.gov

Other trials for Chordoma

Additional recruiting or active studies for the same condition.

See all trials for Chordoma →

← Back to all trials